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ABSTRACT 
Rasashastra, one of the branches of Ayurveda, deals with the pharmacological aspects of drugs, some 
of which have unique attributes. These unique attributes need to be validated and explored using the 
scientific and technological advances of today’s world, which shall open up new avenues for drug 
processing, development and therapeutics in Ayurveda.  
Abhrak Bhasma is one of the drugs of Rasashastra having some peculiar attributes. Acharyas have 
mentioned Shataputi and Sahastraputi Abhrak Bhasma which are indeed unique attributes of Abhrak. 
Shataputi Abhrak Bhasma is regarded as a Rasayan, as given in Rasa Tarangini, which says ‘Abhrak 
Bhasma given 20-100 Putas (incinerations) helps eliminate ailments, when given 100-1000 Putas 
acts like a Rasayan’. 
Review of the current literature available on Rasayanas indicates that Anti-oxidant and 
Immunomodulation are the most studied activities of the Rasayan drugs. The effect 
Immunomodulation has on the human body can be compared to some extent with the effect of 
Rasayan dravyas, given in various Classical texts. In view of this correlation, Shataputi Abhrak 
Bhasma was subjected to Invitro screening to assess its Immunomodulatory effect using the 
Nitroblue Tetrazolium (NBT) assay. The results were self conclusive and indicated that Shataputi 
Abhrak Bhasma brings about stimulation of Leucocytes in concentration dependent manner. 5% and 
10 % solutions of Shataputi Abhrak Bhasma stimulated 93% and 93.5% leucocytes respectively, 
which is an indicator of highly significant phagocytic activity. Thus, the study revalidates the 
reference of Shataputi Abhrak Bhasma as a Rasayan and hence also establishing it as an 
Immunomodulator. 
KEYWORDS: Rasayan, Shataputi Abhrak Bhasma, Immunomodulatory Activity, Phagocytic activity, 
Nitroblue Tetrazolium Test, Leucocytes. 
INTRODUCTION
A number of Rasashastra texts including Rasa 
Tarangini advocate the fact that Abhrak when given 20-
100 Putas, helps in Rognivrutti (curing diseases) but 
when Putas are increased from 100-1000, it acts like a 
Rasayan (prevents disease).[1] An attempt shall be 
made to understand and find a relation between the 
number of Putas and its preclinical efficacy with 
modern concept of Rasayan (Immunomodulation). 
Concept of Rasayan 
 Rasayan is one of the eight branches of 
Ayurveda. The word Rasayan is made up of two words, 
‘Rasa’ and ‘Ayan’. The word Rasa has many meanings. It 
means Shrangara, Visha, Virya, Guna, Raga, Drava etc. 
Ayan means the pathway. Hence literally, Rasayan 
means the pathway to attain best quality of Dhatus. It 
helps maintain the health and also cures and prevents 
ailments.[2] 
 
Benefits of Rasayan Therapy[3,4] 
According to Acharya Charak, Rasayan therapy  
 Enhances the intelligence, memory power, will 
power, body strength, skin lustre, sweetness of 
voice and physical strength. 
 It nourishes the Sapta dhatu and thus prevents 
chronic degenerative changes and illness.  
 Rasayan is thought to improve metabolic processes, 
which results in the best possible biotransformation 
and produce best quality body tissues, eradicate 
senility and thus help prevent diseases of the old 
age. 
 It helps attain optimal physical strength and 
sharpness of sense organs. 
 Rasayan dravyas have significant action on 
reproductive system and nourishes Shukra dhatu. 
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 Rasayan nourishes the whole body, helps maintain 
physiological functions at optimum level, thus also 
improves body’s natural resistance against 
infections by increasing Immunity. 
 Rasayan invigorates the body in general by 
sustaining the required balance between anabolism 
and catabolism. 
 Rasayan therapy which regulates the circulation of 
vital fluid, eliminates the waste product, rejuvenate 
the nervous system as well. 
 It prevents wasting of muscles, delays the ageing 
process, nourishes bones, tendons etc.. Prevents 
osteoporosis, prevents premature greying of hair 
and provides good sleep and appetite. 
 Rasayanas help keep body and mind function at 
their optimum best. 
Probable action of Rasayan according to Modern 
view[5] 
 Rasayan dravyas work as Immunomodulators 
and have antioxidant activity as well. 
 In relation to non specific immunity these drugs 
increase activation of polymorphoneutrophils 
(PMN) for phagocytosis and enhance their chemo-
attractant capacity. 
 In relation to specific immunity, they lead to 
proliferation of lymphocytes leading to production 
and also cytotoxic induction of T-helper and Natural 
Killer (NK) cells and activation of complement 
pathways. Also they significantly increase 
immunoglobulin levels. 
 Immunostimulants offer promise in enhancing 
antigen specific (vaccine) and non-specific immune 
response against infections. 
 Achar Rasayan acts as psycho immunomodulator, 
reduces stress and thus prevents release of free 
radicals and improves Psycho-Neuro Immunity 
(PNI) 
 Till date a lot of research has been done on Rasayan 
dravyas for understanding their pharmacokinetics 
and pharmacodynamics and their probable 
mechanisms of action of various ailments. Majority 
of Rasayan dravyas have been claimed for their 
immunomodulatory effects via.[6] 
 Modulation of cytokine secretion 
  Histamine release 
 Immunoglobulin secretion 
 Class switching 
 Cellular co-receptor expression 
 Lymphocyte expression 
 Phagocytosis 
 Hence the study was planned to evaluate the 
Immunomodulatory activity of Shataputi Abhrak 
Bhasma using modern Immunomodulatory assay. 
 
AIMS AND OBJECTIVES 
 In-vitro Immunomodulatory screening of Shataputi 
Abhrak Bhasma was carried out by means of 
Nitroblue Tetrazolium Dye Test. (NBT assay) 
MATERIALS AND METHODS 
 The present experimental study was carried 
out in the Pharmacology Research Lab of the 
Pharmacology Department of Institute of Chemical 
Technology, Matunga, Mumbai. 
1. Test Drug 
 Shataputi Abhrak Bhasma prepared using 
Electrical Muffle Furnace following Rasa Jala Nidhi 
reference. 
2. Study Design 
In-vitro Screening for Immunomodulatory activity 
using Nitroblue Tetrazolium Test (NBT) [7,8,9,10] 
 The NBT dye reduction test gives information 
about the phagocytic and intracellular killing functions 
of leucocytes which are necessary for normal 
microbiocidal activity. The dye is taken into leucocytes 
by phagocytosis and then stimulation of the hexose 
monophosphate-shunt pathway (HMP) of glucose 
oxidation and concomitant changes in oxidative 
metabolism lead to the reduction of the dye to an 
insoluble blue crystalline form (formazan crystals). 
These blue crystals are visible in the light microscope 
and can be counted. The NBT test gives information 
about phagocytic function, since the dye is not taken 
into cells except by phagocytosis. 
Chemicals and Reagents: 
 Coli Endotoxin Standard: 20 ml of broth from each 
of S strains of E. Coli was boiled in water-bath for 2 
hours, centrifuged at 2000g for 30 mins and the 
supernatant was pooled and stored -20°C. 
 0.15% Nitroblue tetrazolium dye: One part of 0.3% 
Nitroblue Tetrazolium (NBT) solution, prepared in 
0.34% sucrose solution, was added to one part of 
phosphate buffer solution (PBS) and was used 
fresh. 
 Leucocyte suspension: A suspension of leucocytes 
(5 × 106/ml) was prepared in 0.5 ml PBS. 
 Test compounds: Shataputi Abhrak Bhasma 
solutions were prepared in concentrations of 0.5, 1, 
2.5, 5, 10 %. The solutions were centrifuged and 
the supernatants were used in the assay. 
Procedure 
A. Preparation of Leucocytes by Differential Lysis 
of Erythrocytes 
Leucocytes were isolated by centrifugation after 
specific lysis of erythrocytes. 
1. Anticoagulant added whole blood was well-
suspended by gentle inversion and poured into a 
50 ml conical tube. 
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2. 40 mL ice cold lysis buffer was added and mixed 
completely by gentle inversion. 
3. It was kept on ice, mixed occasionally, until 
erythrocytes were lysed. 
4. Centrifuged at 1,500 g for 5 minutes. 
5. Supernatant was discarded by careful vacuum 
aspiration. 
6. The leucocyte pellet was resuspended thoroughly 
in 1 mL ice cold lysis buffer by repeated pipetting. 
7. After the cells have been homogeneously 
resuspended, additional 4 ml icecold lysis buffer 
was added, swirled gently to mix, and kept on ice 
for 10 minutes. 
8. Cell suspension was then diluted to 50 mL with 
icecold 0.9% saline. 
9. Mixed and centrifuged at 1,500 g for 5 minutes. 
10. The supernatant was discarded by gentle vacuum 
aspiration. The leucocyte pellet resuspended 
thoroughly in 1 mL icecold 0.9% saline by 
repeated pipetting until the cell suspension was 
completely homogeneous, & then additional 9 ml 
ice cold 0.9% saline was added and swirled gently 
to mix. 
11. Count the yield of cells on a neubars chamber. 
B. Nitroblue Tetrazolium (NBT) Dye Test 
 The assay mixture consisted of 0.2 ml of 5 × 106/ml 
of leucocyte suspension and 0.2-ml freshly 
prepared 0.15% NBT solution. 
 0.1 ml of test substance at different concentrations 
was added to the reaction mixture. 
 0.1 ml of endotoxin-activated plasma was added to 
the 0.15% NBT solution and leucocytes which 
served as a positive control (standard). 
 A normal control was maintained in another test 
tube with leucocytes suspension, distilled water 
and NBT solution. 
 All the test tubes were incubated separately at 
37ºC for 20 min and centrifuged gently at 400 g for 
3-4 min. The supernatant was discarded.  
 A drop of PBS was added and the cells were gently 
resuspended at the bottom of the test tube.  
 A film was made by allowing a drop of this fluid to 
dry on a microscope slide. 
 Slides were dried for 10-15 mins.  
 Methanol fixation was carried out and again slides 
were kept for drying purpose.  
 Slides were further stained in Giemsa stain for 15 
mins and washed under tap water.  
 After complete drying, the slides were observed 
under light microscope with oil immersion 
objective. 
 300 neutrophils were counted and the % of NBT 
positive cells containing the blue spots 
(stimulated) were determined. 
OBSERVATIONS AND RESULTS 
Table 1: Result for Immunomodulatory Effect (NBT Test) 
S.No. Test Substance % NBT     
positive cells 
1. Normal Control 34.08 
2. Positive Control (Endotoxin 
activated plasma) 
88 
3. 0.5% Shataputi Abhrak 
Bhasma 
75 
4. 1% Shataputi Abhrak 
Bhasma 
84 
5. 2.5% Shataputi Abhrak 
Bhasma 
84.4 
6. 5% Shataputi Abhrak 
Bhasma 
93 
7. 10% Shataputi Abhrak 
Bhasma 
93.5 
DISCUSSIONS 
 Nitroblue tetrazolium dye test is used to assess the 
Immunomodulatory activity of the test compound 
by determining its ability to stimulate the 
phagocytic activity in leucocytes. 
 Once stimulated, the membrane permeable, water-
soluble, yellow-colored, nitroblue tetrazolium is 
reduced to blue NBT formazan crystals by the 
leucocytes. 
 The Shataputi Abhrak Bhasma stimulated 
phagocytic activity of the leucocytes in a 
concentration dependent manner as seen by the 
increased percentage of NBT positive cells. 
CONCLUSION 
 Thus Shataputi Abhrak Bhasma, exhibits a potent 
In-vitro Immunomodulatory (stimulant) activity in 
a concentration dependent manner.  
 The results are self conclusive and indicate that 
Shataputi Abhrak Bhasma brings about stimulation 
of Leucocytes and thus in turn leads to highly 
significant phagocytic activity which is evident 
from the Invitro NBT test.  
 The Immunomodulatory activity of Shataputi 
Abhrak Bhasma is concentration dependent. The 
activity of Shataputi Abhrak Bhasma at 5% and 
10% is even higher than the positive control group 
(Endotoxin Activated Plasma). Thus it can be 
concluded that Shataputi Abhrak Bhasma which is 
highly rated as a Rasayan by various Rasa Shastra 
Granthakars, has a significant Invitro 
Immunomodulatory activity in concentration 
dependent manner. This also validates the 
principle that Shataputi Abhrak Bhasma acts as a 
Rasayan after subjecting to 100 Putas. Animal and 
Clinical trials shall further consolidate the above 
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results and shall help find mechanism of action of 
Immunomodulation of Shataputi Abhrak Bhasma. 
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PHOTOGRAPHS OF INVITRO NBT ASSAY FOR IMMUNOMODULATORY ACTIVITY 
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